Navigation Links
Cornell forges licensing agreement with new New York apple industry group
Date:5/5/2010

ITHACA, N.Y. Cornell University has forged a licensing agreement with a new apple industry group the New York State Apple Growers LLC (NYAG) to grow and market two new, patented premium apple varieties.

Susan Brown, Cornell professor of horticultural at Cornell's New York State Agricultural Experiment Station in Geneva, N.Y., developed the new varieties. The new varieties are Cornell's 65th and 66th apple-variety releases.

Cornell will trademark them with input from NYAG to ensure proper branding, as they have been under development for some 14 years. Their formal names will be announced in the fall.

Both are crisp and firm. The juicy snap of "New York 1" (a placeholder name for the patent) recalls its Honeycrisp parent, but the trees produce more reliably and the fruit stores well. Sweet and tart "New York 2" is suited for baking and fresh use, and boasts the added benefit of higher levels of vitamin C, according to Brown.

The new agreement is a first for Cornell's apple-breeding program, which in the past has publicly released all new varieties to nurseries and growers and has only recovered limited tree royalties.

A new distribution model, called a "managed release," is becoming the norm for university breeding programs to advance the interests of the communities they serve.

Commercialization of new varieties can be challenging in a marketplace dominated by large grocery chains populated by brand savvy consumers. It can take 20 years to successfully commercialize a new type of apple, says Brown. By coordinating the supply and marketing, the managed release agreement will reduce that time by half. And, by receiving some of the return on investment, Cornell's College of Agriculture and Life Sciences can support its breeding program.

All of the nearly 600 apple growers in New York state will have the opportunity to join NYAG this year. Broad participation from growers is key to commercial suc
'/>"/>

Contact: Blaine Friedlander
bpf2@cornell.edu
607-254-8093
Cornell University
Source:Eurekalert

Page: 1 2

Related biology news :

1. Weill Cornell researchers find that a single gene is responsible for OCD-like behaviors in mice
2. Weill Cornell science briefs: November 2009
3. Battling cancer with engineering: NCI funds new $13 million cancer research center led by Cornell
4. Genetic secrets of date palm unlocked by researchers at Weill Cornell Medical College in Qatar
5. NIST-Cornell team builds worlds first nanofluidic device with complex 3-D surfaces
6. Ansary Symposium on Stem Cell Research at Weill Cornell Medical College
7. Cornell gets $10 million NSF grant to establish new sustainability institute
8. During Olympics, Cornells Max Zhang studies air-quality in Beijing
9. Weill Cornell science briefs June/July 2008
10. The 12th International Behavioral Ecology Congress held at Cornell University, Aug. 10-14
11. Weill Cornell team discovers how brains own tPA helps regulate blood flow to neurons
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2014)... drugs already approved by the U.S. Food and Drug ... growth of certain bacterial pathogens inside human cells, including ... fever. The findings, published in mBio , the ... demonstrate a new way of identifying non-antibiotic drugs that ... A handful of drugs on the list inhibit the ...
(Date:7/28/2014)... Amundsen reached the South Pole in 1911, but new ... any human. , Using data from 16 ice cores ... including the South Pole, a group led by Joe ... Nevada, created the most accurate and precise reconstruction to ... new record, described in an article published today in ...
(Date:7/28/2014)... States have a circulatory problem of the legs called ... even require surgery in serious cases. This disease can ... limb amputation. , At The University of Texas Health ... a non-surgical preventative treatment in a mouse model of ... circulation. Their proof-of-concept study appears in the journal ...
Breaking Biology News(10 mins):New route to identify drugs that can fight bacterial infections 2Lead pollution beat explorers to South Pole, persists today 2Lead pollution beat explorers to South Pole, persists today 3Scientists discover genetic switch that can prevent peripheral vascular disease in mice 2
... from reducing cholesterol and having anticancerogenic properties, is characterised ... which genes are responsible for this activity ?the reason ... agent, was the aim of the PhD thesis by ... University of Navarre with the title, Molecular Characterisation of ...
... National Institutes of Health (NIH) announced today a new ... articles resulting from NIH-funded research. The policy ?the first ... release to the public manuscripts from research supported by ... of final publication. , These peer-reviewed, NIH-funded research publications ...
... harmless on human skin, but it is the ... indwelling medical devices. S. epidermidis is associated with ... prosthetic joints, replacement heart valves, and intravenous catheters, ... Moreover, the mechanism through which the organism becomes ...
Cached Biology News:Advances in the characterisation of the oyster mushroom genes 2NIH Calls on Scientists to Speed Public Release of Research Publications 2NIH Calls on Scientists to Speed Public Release of Research Publications 3
(Date:7/29/2014)... “PharmaSphere: Emerging Biotech Investment Report Strategic ... report provides in-depth analysis of the current trends ... capital segments of the financial industry, bearing in ... impact on the future of emerging biotechnology companies ... identifies regions of the world that are attracting ...
(Date:7/29/2014)... a particle be separated from its properties? On July ... the results of the first Cheshire Cat experiment, separating ... University in Orange, CA, and Vienna University of Technology. ... a grin," thought Alice in Wonderland, "but a grin ... ever saw in my life!" Alice,s surprise stems from ...
(Date:7/29/2014)... July 29, 2014 Second generation biofuels are ... by fossil fuels. However, as natural gas is very cheap, ... they are not as valuable as they could be in ... difficulty financing projects, has made it difficult for renewable energy ... get off the ground. For these reasons, certain companies have ...
(Date:7/29/2014)... SPRINGS, Colo. , July 29, 2014 /PRNewswire/ ... specializing in cannabis formulation-based drug development and related ... York Times for taking a strong position in ... its Sunday, July 27, 2014 publication.  The New ... editorials and articles this week exploring the issue ...
Breaking Biology Technology:Strategic Trends of Biotech Investment Industry (Private Equity and Venture Capital Funding) in New Report Available at MarketOptimizer.org 2Strategic Trends of Biotech Investment Industry (Private Equity and Venture Capital Funding) in New Report Available at MarketOptimizer.org 3Strategic Trends of Biotech Investment Industry (Private Equity and Venture Capital Funding) in New Report Available at MarketOptimizer.org 4The quantum Cheshire cat: Scientists separate a particle from its properties 2The quantum Cheshire cat: Scientists separate a particle from its properties 3The quantum Cheshire cat: Scientists separate a particle from its properties 4Renewable Waste Intelligence: Could Renewable Chemicals Be the Future for the Renewable Energy Industry? 2Cannabis Science, Inc. (CBIS) Applauds New York Times Editorial Board Stance on 'Repealing Prohibition, Again'; NYT Editorial Is Bell Weather of Change 2Cannabis Science, Inc. (CBIS) Applauds New York Times Editorial Board Stance on 'Repealing Prohibition, Again'; NYT Editorial Is Bell Weather of Change 3
...  Today, the Global Probiotics Council (GPC), a committee formed ... launch of the fifth annual Young Investigator Grant for ... in the amount of $50,000, to promising young researchers. ... the role of probiotics and gastrointestinal microbiota in health ...
... Arcion Therapeutics, a clinical stage biotechnology company developing ... received notice of allowance for a US Patent for ... ARC-2022 is being developed by Arcion for pain associated ... has been evaluated in a single-dose Phase 1 pharmacokinetic ...
... Jan. 4, 2012  Verify Brand™ announces the release ... 4.0 software. VB Enterprise 4.0 is a suite ... client and mobile software applications that enable comprehensive ... Trace® across the supply chain. VB Enterprise ...
Cached Biology Technology:Fifth Cycle of Probiotics & Microbiota Research Grant Announced 2Fifth Cycle of Probiotics & Microbiota Research Grant Announced 3Fifth Cycle of Probiotics & Microbiota Research Grant Announced 4Arcion Receives Notice of Allowance for US Patent for Novel Topical Lidocaine Formulation for Pain 2Verify Brand™ Announces the Release of VB Enterprise 4.0 2
Purified Mouse anti-Hu LAT (pY226) Storage Temperature: Refrigerate(2 to 8C)...
Tris-EDTA Buffer Solution, 1X, pH 8.0, sterile, Molecular Biology Grade...
... the most comprehensive, cost-effective solution to ... incorporated unprecedented quality into both our ... proven detection chemistries and antibodies that ... protocol. It also includes our competitively ...
...
Biology Products: